IP Library Granted Patent US 9,352,152
Granted Patent B2
US 9,352,152 · App. 11/962,667 · Granted May 31, 2016

Equine airway disorders

Inventors: Werner Lindenthaler (Oberperfuss, AT); Ira Sanders (North Bergen, NJ); Norm G. Ducharme (Ithaca, NY)
Assignees: MED-EL Elektromedizinische Geraete GmbH; Cornell University
A61N1/3601A61B5/4836A61N1/0553A61N1/0556A61N1/0558A61N1/37282A61B5/0476A61B5/0488A61B5/04886A61B5/085A61B5/1118A61B5/4848A61B5/4863A61B7/003A61B2503/40A61B2562/0247A61B2562/0261A61N1/0502
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,352,152
App. No.
11/962,667
Granted
May 31, 2016
Kind
B2
Abstract

Airway disorders in a horse are relieved by electrical stimulation of the airway tissue. Particular disorders and techniques include electrical stimulation to relieve laryngeal hemiplegia. A pacemaker processor generates an electrical treatment signal to be applied to upper airway tissue of the horse for treating the upper airway disorder. One or more stimulation electrodes interfaces with the upper airway tissue for delivering the treatment signal to the upper airway tissue.

Claims (30)

1. A device for treating laryngeal hemiplegia in horses, the device comprising:

a pacemaker processor configured to generate an electrical signal to be applied to upper airway tissue of the horse and configured to cause complete and continuous abduction of the vocal fold during a period of minutes up to hours in order to treat the laryngeal hemiplegia; and

one or more stimulation electrodes adapted to interface with the upper airway tissue for delivering the electrical signal to the upper airway tissue.

2. The device of claim 1 , wherein at least a portion of the device is implanted in the horse.

3. The device of claim 2 , wherein the implanted portion of the device communicates transcutaneously or percutaneously with a portion of the device located externally to the horse.

4. The device of claim 3 , wherein communication transcutaneously is based on at least one of electromagnetic induction, acoustic energy, optical energy, and capacitor coupling.

5. The device of claim 2 , wherein a portion of the device is configured to be placed temporarily on the surface of the horse when the device is operating to provide external signals to the implanted portion of the device.

6. The device of claim 2 , wherein the implanted portion includes a power source which is charged percutaneously or transcutaneously.

7. The device of claim 1 , wherein the electrical signal is derived from at least one of an electromyogram, an electronystagmograph, an electroglottograph, an electroencephalograph, a biopotential sensor, an ultrasound sensor, a hall sensor, a microphone, a pressure sensor, a strain transducer, a mechanical deformation sensor, and a motion sensor.

8. The device of claim 1 , wherein the electrical signal is applied to the upper airway tissue of the horse using a biphasic waveform.

9. The device of claim 1 , wherein the one or more stimulation electrodes are based on at least one of a cuff electrode, a multipolar cuff electrode, a tripolar cuff electrode, a flat nerve electrode, an epineural electrode, a shaft electrode, a longitudinal intrafascicular electrode, a thin wire electrode, a micro-machined electrode, a sieve electrode, and a staple electrode.

10. The device of claim 1 , wherein the upper airway tissue includes one or more nerves of an airway structure.

11. The device of claim 10 , wherein the one or more nerves includes the recurrent laryngeal nerve of the horse.

12. The device claim 11 , wherein the upper airway tissue includes one or more axons of the abductor branch of the recurrent laryngeal nerve.

13. The device of claim 1 , further comprising one or more treatment sensors configured to sense at least one therapy parameter related to the horse, wherein the at least one therapy parameter relates to at least one of air flow characteristics of the airway tract of a horse, contractile characteristics of the airway tissue of a horse, electrical characteristics of a portion of the body of the horse, temperature of a portion of the body of the horse, pH of a portion of the body of the horse, chemical constituency of a portion of the body of the horse, and physiological state of the horse.

14. The device of claim 1 , further comprising one or more treatment sensors configured to sense at least one therapy parameter related to the pacemaker processor, the one or more stimulation electrodes, or both.

15. A device for treating laryngeal hemiplegia in horses, the device comprising:

a pacemaker processor configured to generate an electrical signal to be applied to upper airway tissue of the horse and configured to cause continuous abduction of the vocal fold during a period of minutes up to hours in order to treat the laryngeal hemiplegia;

one or more stimulation electrodes adapted to interface with the upper airway tissue for delivering the electrical signal to the upper airway tissue;

one or more treatment sensors configured to sense at least one therapy parameter related to the horse; and

a treatment verification monitor configured to monitor the electrical signal delivered by the one or more stimulation electrodes and to monitor an effect of the at least one therapy parameter on the horse before, during, or after an athletic performance.

16. The device of claim 15 , further comprising:

a record log for recording the at least one therapy parameter.

17. The device of claim 15 , wherein the treatment verification monitor produces an external signal when the pacemaker processor is operating.

18. The device of claim 17 wherein the external signal includes a visible movement of a muscle of the horse accomplished by stimulating the muscle with an electrode.

19. A treatment verification system for verifying proper treatment of laryngeal hemiplegia in a horse, the system comprising:

a pacemaker processor configured to generate an electrical signal to be applied to upper airway tissue of the horse and configured to cause vocal fold abduction continuously during a period of minutes up to hours in order to treat the laryngeal hemiplegia;

one or more stimulation electrodes adapted to interface with upper airway tissue of the horse for delivering the electrical signal to the upper airway tissue of the horse; and

a treatment verification monitor configured to monitor the electrical signal delivered by the one or more stimulation electrodes and to monitor an effect of at least one therapy parameter on the horse before, during, or after an athletic performance.

20. The system of claim 19 , further comprising one or more treatment sensors configured to sense the at least one therapy parameter related to operation of the treatment verification system.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2010
From: DUCHARME, NORM G.
To: CORNELL UNIVERSITY
Reel/Frame 023759/0554 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2009
From: DUCHARME, NORM G.
To: CORNELL CENTER FOR TECHNOLOGY, ENTERPRISE & COMMERCIALIZATION ("CCTEC")
Reel/Frame 023625/0483 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 29, 2008
From: LINDENTHALER, WERNER; SANDERS, IRA
To: MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH
Reel/Frame 021306/0070 →
Continuity (2)
Provisional Application 60871533 · Dec 22, 2006
Related Publication 20080208280A1 · Aug 28, 2008